These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17457692)

  • 1. Regionally selective decreases in cerebral glucose metabolism in a mouse model of phenylketonuria.
    Qin M; Smith CB
    J Inherit Metab Dis; 2007 Jun; 30(3):318-25. PubMed ID: 17457692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral protein synthesis in a genetic mouse model of phenylketonuria.
    Smith CB; Kang J
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):11014-9. PubMed ID: 11005872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pah
    Lu LH; Xia ZX; Guo JL; Xiao LL; Zhang YJ
    CNS Neurosci Ther; 2020 Apr; 26(4):486-493. PubMed ID: 31471952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bone mineralization defect in the Pah
    Dobrowolski SF; Tourkova IL; Robinson LJ; Secunda C; Spridik K; Blair HC
    Mol Genet Metab; 2018 Nov; 125(3):193-199. PubMed ID: 30201326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.
    Dobrowolski SF; Lyons-Weiler J; Spridik K; Vockley J; Skvorak K; Biery A
    Mol Genet Metab; 2016 Sep; 119(1-2):1-7. PubMed ID: 26822703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset behavioral and neurochemical deficits in the genetic mouse model of phenylketonuria.
    Fiori E; Oddi D; Ventura R; Colamartino M; Valzania A; D'Amato FR; Bruinenberg V; van der Zee E; Puglisi-Allegra S; Pascucci T
    PLoS One; 2017; 12(8):e0183430. PubMed ID: 28850618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylketonuria: Direct and indirect effects of phenylalanine.
    Schlegel G; Scholz R; Ullrich K; Santer R; Rune GM
    Exp Neurol; 2016 Jul; 281():28-36. PubMed ID: 27091224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
    Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO
    Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria.
    Pascucci T; Giacovazzo G; Andolina D; Conversi D; Cruciani F; Cabib S; Puglisi-Allegra S
    J Inherit Metab Dis; 2012 Nov; 35(6):1001-9. PubMed ID: 22447154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles in the brain of phenylketonuria mouse model reversed by the low phenylalanine diet therapy.
    Hong S; Zhu T; Zheng S; Zhan X; Xu F; Gu X; Liang L
    Metab Brain Dis; 2021 Dec; 36(8):2405-2414. PubMed ID: 34524592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell energy deficit and oxidative stress contribute to osteopenia in the Pah
    Dobrowolski SF; Sudano C; Phua YL; Tourkova IL; Spridik K; Goetzman ES; Vockley J; Blair HC
    Mol Genet Metab; 2021 Mar; 132(3):173-179. PubMed ID: 33602601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.
    Oh HJ; Park ES; Kang S; Jo I; Jung SC
    Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU).
    Surendran S; Matalon D; Tyring SK; Rady PL; Velagaleti GV; Matalon R
    Neurosci Lett; 2005 Jul; 382(3):323-6. PubMed ID: 15925112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolomics in the Pah
    Dobrowolski SF; Phua YL; Sudano C; Spridik K; Zinn PO; Wang Y; Bharathi S; Vockley J; Goetzman E
    Mol Genet Metab; 2022 May; 136(1):38-45. PubMed ID: 35367142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal synaptic connectivity in phenylketonuria.
    Horling K; Schlegel G; Schulz S; Vierk R; Ullrich K; Santer R; Rune GM
    Hum Mol Genet; 2015 Feb; 24(4):1007-18. PubMed ID: 25296915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice.
    Mochizuki S; Mizukami H; Ogura T; Kure S; Ichinohe A; Kojima K; Matsubara Y; Kobayahi E; Okada T; Hoshika A; Ozawa K; Kume A
    Gene Ther; 2004 Jul; 11(13):1081-6. PubMed ID: 15057263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria.
    Cabib S; Pascucci T; Ventura R; Romano V; Puglisi-Allegra S
    Behav Genet; 2003 May; 33(3):301-10. PubMed ID: 12837019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
    Winn SR; Scherer T; Thöny B; Harding CO
    Mol Genet Metab; 2016 Jan; 117(1):5-11. PubMed ID: 26653793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of neurogenic amines in phenylketonuria mice after liver-targeted gene therapy.
    Yagi H; Sanechika S; Ichinose H; Sumi-Ichinose C; Mizukami H; Urabe M; Ozawa K; Kume A
    Neuroreport; 2012 Jan; 23(1):30-4. PubMed ID: 22107842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the mouse phenylalanine hydroxylase mutation Pah(enu3).
    Haefele MJ; White G; McDonald JD
    Mol Genet Metab; 2001 Jan; 72(1):27-30. PubMed ID: 11161825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.